CY1113971T1 - Νεα παραγωγα αζαδικυκλο [3.2.0] επτ-3-υλ, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις που τα περιεχουν - Google Patents

Νεα παραγωγα αζαδικυκλο [3.2.0] επτ-3-υλ, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις που τα περιεχουν

Info

Publication number
CY1113971T1
CY1113971T1 CY20131100354T CY131100354T CY1113971T1 CY 1113971 T1 CY1113971 T1 CY 1113971T1 CY 20131100354 T CY20131100354 T CY 20131100354T CY 131100354 T CY131100354 T CY 131100354T CY 1113971 T1 CY1113971 T1 CY 1113971T1
Authority
CY
Cyprus
Prior art keywords
azadicycle
ept
producers
preparing
new
Prior art date
Application number
CY20131100354T
Other languages
English (en)
Inventor
Patrick Casara
Anne-Marie Chollet
Alain Dhainaut
Pierre Lestage
Fany Panayi
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of CY1113971T1 publication Critical patent/CY1113971T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Ενώσεις του τύπου (I):
CY20131100354T 2009-12-09 2013-04-29 Νεα παραγωγα αζαδικυκλο [3.2.0] επτ-3-υλ, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις που τα περιεχουν CY1113971T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0905957A FR2953514B1 (fr) 2009-12-09 2009-12-09 Nouveaux derives azabicyclo[3.2.0]hept-3-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP10290642A EP2332910B1 (fr) 2009-12-09 2010-12-08 Nouveaux dérivés azabicyclo[3.2.0] hept-3-yl, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
CY1113971T1 true CY1113971T1 (el) 2016-07-27

Family

ID=42133738

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100354T CY1113971T1 (el) 2009-12-09 2013-04-29 Νεα παραγωγα αζαδικυκλο [3.2.0] επτ-3-υλ, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις που τα περιεχουν

Country Status (44)

Country Link
US (1) US8008337B2 (el)
EP (1) EP2332910B1 (el)
JP (1) JP5511645B2 (el)
KR (1) KR101292705B1 (el)
CN (1) CN102127004B (el)
AP (1) AP2755A (el)
AR (1) AR079268A1 (el)
AU (1) AU2010246426B2 (el)
BR (1) BRPI1005270A2 (el)
CA (1) CA2724151C (el)
CL (1) CL2010001309A1 (el)
CO (1) CO6280059A1 (el)
CR (1) CR11811A (el)
CU (1) CU23993B1 (el)
CY (1) CY1113971T1 (el)
DK (1) DK2332910T3 (el)
EA (1) EA018971B1 (el)
EC (1) ECSP10010649A (el)
ES (1) ES2405206T3 (el)
FR (1) FR2953514B1 (el)
GE (1) GEP20135801B (el)
HN (1) HN2010002593A (el)
HR (1) HRP20130307T1 (el)
IL (1) IL209463A (el)
JO (1) JO2880B1 (el)
MA (1) MA32444B1 (el)
ME (1) ME01504B (el)
MX (1) MX2010013093A (el)
MY (1) MY150598A (el)
NI (1) NI201000206A (el)
NZ (1) NZ589763A (el)
PE (1) PE20110542A1 (el)
PL (1) PL2332910T3 (el)
PT (1) PT2332910E (el)
RS (1) RS52698B (el)
SA (1) SA110320007B1 (el)
SG (1) SG172543A1 (el)
SI (1) SI2332910T1 (el)
SV (1) SV2010003746A (el)
TW (1) TWI419875B (el)
UA (1) UA106721C2 (el)
UY (1) UY33046A (el)
WO (1) WO2011070250A1 (el)
ZA (1) ZA201008651B (el)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9300625B (sl) * 1993-12-02 2002-02-28 Basf Aktiengesellschaft N-substituirani derivati azabicikloheptana, njihova priprava in uporaba
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2953514A1 (fr) 2011-06-10
IL209463A (en) 2014-06-30
CA2724151C (fr) 2013-03-26
AP2755A (en) 2013-09-30
ME01504B (me) 2014-04-20
IL209463A0 (en) 2011-02-28
SV2010003746A (es) 2011-03-15
JP5511645B2 (ja) 2014-06-04
EP2332910B1 (fr) 2013-01-30
ES2405206T3 (es) 2013-05-30
AR079268A1 (es) 2012-01-04
PL2332910T3 (pl) 2013-06-28
US8008337B2 (en) 2011-08-30
CO6280059A1 (es) 2011-05-20
KR101292705B1 (ko) 2013-08-02
RS52698B (en) 2013-08-30
JP2011121945A (ja) 2011-06-23
EP2332910A1 (fr) 2011-06-15
SI2332910T1 (sl) 2013-05-31
CL2010001309A1 (es) 2012-01-13
JO2880B1 (en) 2015-03-15
GEP20135801B (en) 2013-04-10
HRP20130307T1 (hr) 2013-04-30
AU2010246426B2 (en) 2013-06-27
MY150598A (en) 2014-01-30
KR20110065384A (ko) 2011-06-15
NI201000206A (es) 2014-01-07
EA018971B1 (ru) 2013-12-30
WO2011070250A1 (fr) 2011-06-16
US20110136886A1 (en) 2011-06-09
PE20110542A1 (es) 2011-08-18
HN2010002593A (es) 2013-03-18
ZA201008651B (en) 2011-10-26
TW201200498A (en) 2012-01-01
DK2332910T3 (da) 2013-05-13
ECSP10010649A (es) 2011-07-29
SA110320007B1 (ar) 2013-10-03
MA32444B1 (fr) 2011-07-03
PT2332910E (pt) 2013-02-26
NZ589763A (en) 2012-05-25
AU2010246426A1 (en) 2011-06-23
UY33046A (es) 2011-05-31
CU20100236A7 (es) 2011-11-15
AP2010005489A0 (en) 2010-12-31
SG172543A1 (en) 2011-07-28
UA106721C2 (uk) 2014-10-10
CN102127004B (zh) 2013-10-23
TWI419875B (zh) 2013-12-21
FR2953514B1 (fr) 2011-12-23
BRPI1005270A2 (pt) 2013-04-30
CA2724151A1 (fr) 2011-06-09
MX2010013093A (es) 2011-06-14
CN102127004A (zh) 2011-07-20
CU23993B1 (es) 2014-04-24
CR11811A (es) 2011-02-04
EA201001755A1 (ru) 2011-10-31

Similar Documents

Publication Publication Date Title
EA201170772A1 (ru) Органические соединения
MY153915A (en) Organic compounds
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
SG178952A1 (en) Chemical compounds
IL204437A (en) History of aryl cyclic profile and their use
MX2011008864A (es) Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales.
CY1112495T1 (el) Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
MX2009000884A (es) Derivados de piridizinona.
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
CY1111367T1 (el) Νεα παραγωγα της διοσμετινης, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
CY1113914T1 (el) Νεα παραγωγα διυδροϊνδολονων, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
MX2012004780A (es) Inhibidores de akt.
MX2010008051A (es) Nuevos derivados de fluoroglicosidos aromaticos, productos farmaceuticos que comprenden dichos compuestos y uso de los mismos.
CY1109637T1 (el) Νεα τρικυκλικα παραγωγα, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
MX2009006750A (es) Derivados de azaadamantano espirociclicos y metodos de uso.
EA201600122A1 (ru) Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их
CY1110944T1 (el) Νεα παραγωγα κυκλοαλκυλιωμενων βενζοθειαδιαζινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν